Literature DB >> 26621887

Numbers needed to treat to prevent tuberculosis.

Martina Sester1, Reinout van Crevel2, Frank van Leth3, Christoph Lange4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26621887     DOI： 10.1183/13993003.01047-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.

Authors:  S Swindells; M Siccardi; S E Barrett; D B Olsen; J A Grobler; A T Podany; E Nuermberger; P Kim; C E Barry; A Owen; D Hazuda; C Flexner
Journal:  Int J Tuberc Lung Dis       Date:  2018-02-01       Impact factor: 2.373

2.  Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.

Authors:  K Sullivan; C Pease; A Zwerling; R Mallick; D Van Dyk; S Mulpuru; C Allen; H Alsdurf; G G Alvarez
Journal:  BMC Public Health       Date:  2021-05-21       Impact factor: 3.295

3.  Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.

Authors:  Sara Suliman; Ethan G Thompson; Jayne Sutherland; January Weiner; Martin O C Ota; Smitha Shankar; Adam Penn-Nicholson; Bonnie Thiel; Mzwandile Erasmus; Jeroen Maertzdorf; Fergal J Duffy; Philip C Hill; E Jane Hughes; Kim Stanley; Katrina Downing; Michelle L Fisher; Joe Valvo; Shreemanta K Parida; Gian van der Spuy; Gerard Tromp; Ifedayo M O Adetifa; Simon Donkor; Rawleigh Howe; Harriet Mayanja-Kizza; W Henry Boom; Hazel M Dockrell; Tom H M Ottenhoff; Mark Hatherill; Alan Aderem; Willem A Hanekom; Thomas J Scriba; Stefan H E Kaufmann; Daniel E Zak; Gerhard Walzl
Journal:  Am J Respir Crit Care Med       Date:  2018-05-01       Impact factor: 30.528

4.  Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor.

Authors:  Lionel Hon Wai Lum; Fei Wen Chen; Louise Jackett; Simone I Strasser; Rebecca J Davis
Journal:  Transplant Direct       Date:  2017-06-06

5.  Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.

Authors:  Christoph Lange; Anna M Mandalakas; Barbara Kalsdorf; Claudia M Denkinger; Martina Sester
Journal:  Pathog Immun       Date:  2016-01-04

Review 6.  Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis.

Authors:  Elisa Petruccioli; Thomas J Scriba; Linda Petrone; Mark Hatherill; Daniela M Cirillo; Simone A Joosten; Tom H Ottenhoff; Claudia M Denkinger; Delia Goletti
Journal:  Eur Respir J       Date:  2016-11-11       Impact factor: 16.671

Review 7.  The Tuberculosis Network European Trials Group (TBNET): new directions in the management of tuberculosis.

Authors:  Graham Bothamley
Journal:  Breathe (Sheff)       Date:  2017-09

8.  Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection.

Authors:  Hellen Hiza; Lukas Fenner; Jerry Hella; Davis Kuchaka; Mohamed Sasamalo; Thomas Blauenfeldt; Gibson Kibiki; Reginald A Kavishe; Francis Mhimbira; Morten Ruhwald
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

9.  Conversion of Tuberculosis Screening Tests During Biologic Therapy Among Veteran Patient Population With Rheumatic Disease.

Authors:  Debendra Pattanaik; Sandeep Gupta; Syed Islam; Kunal Singhal; Syed Raza
Journal:  ACR Open Rheumatol       Date:  2019-08-29

Review 10.  Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB.

Authors:  Elisa H Ignatius; Susan Swindells
Journal:  Curr HIV/AIDS Rep       Date:  2020-12       Impact factor: 5.495
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.